BioNukleo GmbH
Your partner for enzymatic synthesis of modified nucleosides and nucleotides
About BioNukleo
BioNukleo develops new (chemo-) enzymatic synthesis routes for nucleic acid derivatives. Due to our strong competence in the expression of challenging proteins, we have set up enzyme libraries with wide substrate promiscuity. They allow for the production of a broad range of nucleoside and nucleotide analogs.
We strive to make nucleoside analog production less complicated, less polluting and less costly!
- Founding: 2014
- Focus : Service
- Employees: 1-10
- Industry : Biotechnology